1go9: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 20: | Line 20: | ||
==About this Structure== | ==About this Structure== | ||
1GO9 is a | 1GO9 is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1GO9 OCA]. | ||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID:12473096</ref><references group="xtra"/> | |||
[[Category: Cordopatis, P.]] | [[Category: Cordopatis, P.]] | ||
[[Category: Pairas, G.]] | [[Category: Pairas, G.]] | ||
| Line 35: | Line 34: | ||
[[Category: Synthetic analogue]] | [[Category: Synthetic analogue]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Feb 17 14:04:38 2009'' | ||
Revision as of 12:04, 17 February 2009
MONITORING THE STRUCTURAL CONSEQUENCES OF PHE12-->D-PHE12 AND LEU15-->AIB15 SUBSTITUTION IN H/R CORTICOTROPIN RELEASING HORMONE: IMPLICATIONS FOR DESIGN OF CRH ANTAGONISTS.
Template:ABSTRACT PUBMED 12473096
About this Structure
1GO9 is a 1 chain structure. Full experimental information is available from OCA.
Reference
- Spyroulias GA, Papazacharias S, Pairas G, Cordopatis P. Monitoring the structural consequences of Phe12-->D-Phe and Leu15-->Aib substitution in human/rat corticotropin releasing hormone. Implications for design of CRH antagonists. Eur J Biochem. 2002 Dec;269(24):6009-19. PMID:12473096
Page seeded by OCA on Tue Feb 17 14:04:38 2009
